Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefditoren pivoxil vs cefuroxime axetil in acute mild to moderate respiratory and urinary tract infections
CTR20150519Phase 3Active
- Sponsor
- Beijing Boshi Antai Technology Development
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefditoren in acute respiratory illness (ARI), Acute Urinary Tract Infection (UTI), sponsored by Beijing Boshi Antai Technology Development. Started Mar 2017; status: active.
02
Drugs
cefditoren
03
Conditions
acute respiratory illness (ARI)Acute Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20150519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150519.